Apple, Inc AAPL
S&P 500 ETF Trust SPDR SPY
Alphabet Inc. - Class A Shares GOOGL
Microsoft Corporation MSFT
Meta Platforms Inc META
Netflix, Inc. NFLX
Amazon.com Inc. AMZN
Spotify Technology SA SPOT

Cyclerion Therapeutics Inc Share Price

CYCN

NAQ

$1.25

+$0.04

(3.31%)

Industry: Biotechnology Sector: Health Care

Cyclerion Therapeutics Inc Analyst Forecast

Overview Returns Financials Ratios News FAQs

Cyclerion Therapeutics Inc Share Price Chart

Cyclerion Therapeutics Inc Key Stock Metrics

Market Cap info-icon

This is a company’s total value as determined by the stock market. It is calculated by multiplying the total number of a company's outstanding shares by the current market price of one share.

$4.76M

P/E Ratio

This is the ratio of a security’s current share price to its earnings per share. This ratio determines the relative value of a company’s share.

Volume

This is the total number of shares traded during the most recent trading day.

58.68K

Avg Volume info-icon

This is the average number of shares traded during the most recent 30 days.

Dividend Yield info-icon

This ratio shows how much income you earn in dividend payouts per year for every dollar invested in the stock (or the stock’s annual dividend payment expressed as a percentage of its current price).

0.00%

Beta

This measures the expected move in a stock’s price relative to movements in the overall market. The market, such as the S&P 500 Index, has a beta of 1.0. If a stock has a Beta greater (or lower) than 1.0, it suggests that the stock is more (or less) volatile than the broader market.

0.95

52-week Range info-icon

This shows the range of the stock’s price between the 52-week high (the highest price of the stock for the past 52 weeks) and the 52-week low (the lowest price of the stock for the past 52 weeks).

$1.03 L

$3.79 H

$1.25

About Cyclerion Therapeutics Inc, Common Stock

Cyclerion Therapeutics, Inc., a biopharmaceutical company, develops treatments for serious diseases serious diseases with novel sGC stimulators in both the central nervous system (CNS) and the periphery. It is developing Olinciguat, an orally administered vascular soluble guanylate cyclase (sGC) stimulator, which is in Phase 2 clinical trial to treat cardiovascular diseases; and Praliciguat, a systemic sGC stimulator for the treatment of rare kidney disease. It has a license agreement with Akebia to develop, manufacture, medical affair, and commercializes Praliciguat and other related products. The company was incorporated in 2018 and is headquartered in Cambridge, Massachusetts. more

Industry: BiotechnologySector: Health Care

Cyclerion Therapeutics Inc Stock Returns

Time Frame	CYCN	Sector	S&P500
1-Week Return	13.64%	-0.03%	-1.38%
1-Month Return	-18.3%	0.59%	-1.81%
3-Month Return	-13.19%	3.23%	1.38%
6-Month Return	-49.39%	18.29%	5.68%
1-Year Return	-58.75%	7.71%	11.74%
3-Year Return	-92.18%	18.03%	65.15%
5-Year Return	-98.64%	35.78%	73.68%
10-Year Return	-99.5%	140.42%	260.03%

Time Frame	CYCN	Sector	S&P500
1-Week Return	78,524.29%	-1.55%	-51.55%
1-Month Return	-91.45%	7.42%	-19.93%
3-Month Return	-43.65%	13.76%	5.72%
6-Month Return	-74.87%	40.58%	11.85%
1-Year Return	-58.75%	7.71%	11.74%
3-Year Return	-57.24%	5.68%	18.20%
5-Year Return	-57.66%	6.31%	11.67%
10-Year Return	-41.13%	9.17%	13.67%

Cyclerion Therapeutics Inc Financials

	Dec '20	Dec '21	Dec '22	Dec '23	Dec '24	5YR TREND
Total Revenue	2.30M	3.32M	297.00K	-	2.00M	[{"date":"2020-12-31","value":69.16,"profit":true},{"date":"2021-12-31","value":100,"profit":true},{"date":"2022-12-31","value":8.95,"profit":true},{"date":"2023-12-31","value":"-","profit":true},{"date":"2024-12-31","value":60.24,"profit":true}]
Cost of Revenue	56.41M	472.00K	5.58M	-	-	[{"date":"2020-12-31","value":100,"profit":true},{"date":"2021-12-31","value":0.84,"profit":true},{"date":"2022-12-31","value":9.89,"profit":true},{"date":"2023-12-31","value":"-","profit":true},{"date":"2024-12-31","value":"-","profit":true}]
Gross Profit	(54.12M)	3.32M	(5.28M)	-	2.00M	[{"date":"2020-12-31","value":-1630.06,"profit":false},{"date":"2021-12-31","value":100,"profit":true},{"date":"2022-12-31","value":-159.1,"profit":false},{"date":"2023-12-31","value":"-","profit":true},{"date":"2024-12-31","value":60.24,"profit":true}]
Gross Margin	(2357.06%)	100.00%	(1778.45%)	-	100.00%	[{"date":"2020-12-31","value":-2357.06,"profit":false},{"date":"2021-12-31","value":100,"profit":true},{"date":"2022-12-31","value":-1778.45,"profit":false},{"date":"2023-12-31","value":"-","profit":true},{"date":"2024-12-31","value":100,"profit":true}]

Operating Expenses	27.15M	58.52M	13.26M	12.95M	5.63M	[{"date":"2020-12-31","value":46.39,"profit":true},{"date":"2021-12-31","value":100,"profit":true},{"date":"2022-12-31","value":22.66,"profit":true},{"date":"2023-12-31","value":22.13,"profit":true},{"date":"2024-12-31","value":9.62,"profit":true}]
Operating Income	(81.27M)	(55.20M)	(18.54M)	(12.95M)	(3.63M)	[{"date":"2020-12-31","value":-8126500000,"profit":false},{"date":"2021-12-31","value":-5519500000,"profit":false},{"date":"2022-12-31","value":-1854000000,"profit":false},{"date":"2023-12-31","value":-1295100000,"profit":false},{"date":"2024-12-31","value":-362800000,"profit":false}]
Total Non-Operating Income/Expense	4.05M	3.53M	588.00K	747.00K	779.00K	[{"date":"2020-12-31","value":100,"profit":true},{"date":"2021-12-31","value":87.19,"profit":true},{"date":"2022-12-31","value":14.51,"profit":true},{"date":"2023-12-31","value":18.44,"profit":true},{"date":"2024-12-31","value":19.23,"profit":true}]
Pre-Tax Income	(77.80M)	(51.65M)	(18.25M)	(12.59M)	(3.06M)	[{"date":"2020-12-31","value":-7780200000,"profit":false},{"date":"2021-12-31","value":-5164700000,"profit":false},{"date":"2022-12-31","value":-1824600000,"profit":false},{"date":"2023-12-31","value":-1259300000,"profit":false},{"date":"2024-12-31","value":-305700000,"profit":false}]
Income Taxes	(5.13M)	16.00K	(294.00K)	8.42M	-	[{"date":"2020-12-31","value":-60.94,"profit":false},{"date":"2021-12-31","value":0.19,"profit":true},{"date":"2022-12-31","value":-3.49,"profit":false},{"date":"2023-12-31","value":100,"profit":true},{"date":"2024-12-31","value":"-","profit":true}]
Income After Taxes	(72.67M)	(51.66M)	(17.95M)	(21.02M)	-	[{"date":"2020-12-31","value":-7267000000,"profit":false},{"date":"2021-12-31","value":-5166300000,"profit":false},{"date":"2022-12-31","value":-1795200000,"profit":false},{"date":"2023-12-31","value":-2101500000,"profit":false},{"date":"2024-12-31","value":"-","profit":true}]

Income From Continuous Operations	(80.68M)	(51.65M)	(44.08M)	(41.05M)	(3.06M)	[{"date":"2020-12-31","value":-8067700000,"profit":false},{"date":"2021-12-31","value":-5164700000,"profit":false},{"date":"2022-12-31","value":-4407800000,"profit":false},{"date":"2023-12-31","value":-4105400000,"profit":false},{"date":"2024-12-31","value":-305700000,"profit":false}]
Income From Discontinued Operations	-	-	-	-	-	[{"date":"2020-12-31","value":"-","profit":true},{"date":"2021-12-31","value":"-","profit":true},{"date":"2022-12-31","value":"-","profit":true},{"date":"2023-12-31","value":"-","profit":true},{"date":"2024-12-31","value":"-","profit":true}]
Net Income	(77.80M)	(51.65M)	(44.08M)	(5.26M)	(3.06M)	[{"date":"2020-12-31","value":-7780200000,"profit":false},{"date":"2021-12-31","value":-5164700000,"profit":false},{"date":"2022-12-31","value":-4407800000,"profit":false},{"date":"2023-12-31","value":-526300000,"profit":false},{"date":"2024-12-31","value":-305700000,"profit":false}]

EPS (Diluted)	(2.65)	(1.43)	(1.02)	(2.61)	(1.22)	[{"date":"2020-12-31","value":-265,"profit":false},{"date":"2021-12-31","value":-143,"profit":false},{"date":"2022-12-31","value":-102,"profit":false},{"date":"2023-12-31","value":-260.54,"profit":false},{"date":"2024-12-31","value":-122.3,"profit":false}]

	Dec '20	Dec '21	Dec '22	Dec '23	Dec '24	5YR TREND
Total Revenue	-	44.60%	(91.05%)	-	-	[{"date":"2020-12-31","value":"-","profit":true},{"date":"2021-12-31","value":100,"profit":true},{"date":"2022-12-31","value":-204.16,"profit":false},{"date":"2023-12-31","value":"-","profit":true},{"date":"2024-12-31","value":"-","profit":true}]
Cost of Revenue	-	(99.16%)	1081.99%	-	-	[{"date":"2020-12-31","value":"-","profit":true},{"date":"2021-12-31","value":-9.16,"profit":false},{"date":"2022-12-31","value":100,"profit":true},{"date":"2023-12-31","value":"-","profit":true},{"date":"2024-12-31","value":"-","profit":true}]
Gross Profit	-	(106.13%)	(259.10%)	-	-	[{"date":"2020-12-31","value":"-","profit":true},{"date":"2021-12-31","value":null,"profit":false},{"date":"2022-12-31","value":null,"profit":false},{"date":"2023-12-31","value":"-","profit":true},{"date":"2024-12-31","value":"-","profit":true}]
Gross Margin	-	(104.24%)	(1878.45%)	-	-	[{"date":"2020-12-31","value":"-","profit":true},{"date":"2021-12-31","value":null,"profit":false},{"date":"2022-12-31","value":null,"profit":false},{"date":"2023-12-31","value":"-","profit":true},{"date":"2024-12-31","value":"-","profit":true}]

Operating Expenses	-	115.55%	(77.34%)	(2.32%)	(56.54%)	[{"date":"2020-12-31","value":"-","profit":true},{"date":"2021-12-31","value":100,"profit":true},{"date":"2022-12-31","value":-66.94,"profit":false},{"date":"2023-12-31","value":-2,"profit":false},{"date":"2024-12-31","value":-48.94,"profit":false}]
Operating Income	-	(32.08%)	(66.41%)	(30.15%)	(71.99%)	[{"date":"2020-12-31","value":"-","profit":true},{"date":"2021-12-31","value":null,"profit":false},{"date":"2022-12-31","value":null,"profit":false},{"date":"2023-12-31","value":null,"profit":false},{"date":"2024-12-31","value":null,"profit":false}]
Total Non-Operating Income/Expense	-	(12.81%)	(83.35%)	27.04%	4.28%	[{"date":"2020-12-31","value":"-","profit":true},{"date":"2021-12-31","value":-47.38,"profit":false},{"date":"2022-12-31","value":-308.25,"profit":false},{"date":"2023-12-31","value":100,"profit":true},{"date":"2024-12-31","value":15.84,"profit":true}]
Pre-Tax Income	-	(33.62%)	(64.67%)	(30.98%)	(75.72%)	[{"date":"2020-12-31","value":"-","profit":true},{"date":"2021-12-31","value":null,"profit":false},{"date":"2022-12-31","value":null,"profit":false},{"date":"2023-12-31","value":null,"profit":false},{"date":"2024-12-31","value":null,"profit":false}]
Income Taxes	-	(100.31%)	(1937.50%)	(2964.63%)	-	[{"date":"2020-12-31","value":"-","profit":true},{"date":"2021-12-31","value":null,"profit":false},{"date":"2022-12-31","value":null,"profit":false},{"date":"2023-12-31","value":null,"profit":false},{"date":"2024-12-31","value":"-","profit":true}]
Income After Taxes	-	(28.91%)	(65.25%)	17.06%	-	[{"date":"2020-12-31","value":"-","profit":true},{"date":"2021-12-31","value":-169.42,"profit":false},{"date":"2022-12-31","value":-382.44,"profit":false},{"date":"2023-12-31","value":100,"profit":true},{"date":"2024-12-31","value":"-","profit":true}]

Income From Continuous Operations	-	(35.98%)	(14.66%)	(6.86%)	(92.55%)	[{"date":"2020-12-31","value":"-","profit":true},{"date":"2021-12-31","value":null,"profit":false},{"date":"2022-12-31","value":null,"profit":false},{"date":"2023-12-31","value":null,"profit":false},{"date":"2024-12-31","value":null,"profit":false}]
Income From Discontinued Operations	-	-	-	-	-	[{"date":"2020-12-31","value":"-","profit":true},{"date":"2021-12-31","value":"-","profit":true},{"date":"2022-12-31","value":"-","profit":true},{"date":"2023-12-31","value":"-","profit":true},{"date":"2024-12-31","value":"-","profit":true}]
Net Income	-	(33.62%)	(14.66%)	(88.06%)	(41.92%)	[{"date":"2020-12-31","value":"-","profit":true},{"date":"2021-12-31","value":null,"profit":false},{"date":"2022-12-31","value":null,"profit":false},{"date":"2023-12-31","value":null,"profit":false},{"date":"2024-12-31","value":null,"profit":false}]

EPS (Diluted)	-	(46.04%)	(28.67%)	155.43%	(53.06%)	[{"date":"2020-12-31","value":"-","profit":true},{"date":"2021-12-31","value":-29.62,"profit":false},{"date":"2022-12-31","value":-18.45,"profit":false},{"date":"2023-12-31","value":100,"profit":true},{"date":"2024-12-31","value":-34.14,"profit":false}]

	Sep '24	Dec '24	Mar '25	Jun '25	Sep '25	TREND
Total Revenue	194.00K	1.81M	81.00K	93.00K	875.00K	[{"date":"2024-09-30","value":10.74,"profit":true},{"date":"2024-12-31","value":100,"profit":true},{"date":"2025-03-31","value":4.49,"profit":true},{"date":"2025-06-30","value":5.15,"profit":true},{"date":"2025-09-30","value":48.45,"profit":true}]
Cost of Revenue	-	-	-	-	-	[{"date":"2024-09-30","value":"-","profit":true},{"date":"2024-12-31","value":"-","profit":true},{"date":"2025-03-31","value":"-","profit":true},{"date":"2025-06-30","value":"-","profit":true},{"date":"2025-09-30","value":"-","profit":true}]
Gross Profit	194.00K	1.81M	81.00K	93.00K	875.00K	[{"date":"2024-09-30","value":10.74,"profit":true},{"date":"2024-12-31","value":100,"profit":true},{"date":"2025-03-31","value":4.49,"profit":true},{"date":"2025-06-30","value":5.15,"profit":true},{"date":"2025-09-30","value":48.45,"profit":true}]
Gross Margin	100.00%	100.00%	100.00%	100.00%	100.00%	[{"date":"2024-09-30","value":100,"profit":true},{"date":"2024-12-31","value":100,"profit":true},{"date":"2025-03-31","value":100,"profit":true},{"date":"2025-06-30","value":100,"profit":true},{"date":"2025-09-30","value":100,"profit":true}]

Operating Expenses	1.32M	1.30M	1.54M	1.76M	1.88M	[{"date":"2024-09-30","value":70.28,"profit":true},{"date":"2024-12-31","value":69.32,"profit":true},{"date":"2025-03-31","value":81.77,"profit":true},{"date":"2025-06-30","value":93.83,"profit":true},{"date":"2025-09-30","value":100,"profit":true}]
Operating Income	(1.13M)	502.00K	(1.46M)	(1.67M)	(1.01M)	[{"date":"2024-09-30","value":-224.7,"profit":false},{"date":"2024-12-31","value":100,"profit":true},{"date":"2025-03-31","value":-290.24,"profit":false},{"date":"2025-06-30","value":-333.07,"profit":false},{"date":"2025-09-30","value":-200.4,"profit":false}]
Total Non-Operating Income/Expense	447.00K	56.00K	56.00K	1.38M	60.00K	[{"date":"2024-09-30","value":32.41,"profit":true},{"date":"2024-12-31","value":4.06,"profit":true},{"date":"2025-03-31","value":4.06,"profit":true},{"date":"2025-06-30","value":100,"profit":true},{"date":"2025-09-30","value":4.35,"profit":true}]
Pre-Tax Income	(723.00K)	530.00K	(1.43M)	(324.00K)	(976.00K)	[{"date":"2024-09-30","value":-136.42,"profit":false},{"date":"2024-12-31","value":100,"profit":true},{"date":"2025-03-31","value":-269.62,"profit":false},{"date":"2025-06-30","value":-61.13,"profit":false},{"date":"2025-09-30","value":-184.15,"profit":false}]
Income Taxes	-	-	-	-	-	[{"date":"2024-09-30","value":"-","profit":true},{"date":"2024-12-31","value":"-","profit":true},{"date":"2025-03-31","value":"-","profit":true},{"date":"2025-06-30","value":"-","profit":true},{"date":"2025-09-30","value":"-","profit":true}]
Income After Taxes	-	-	-	-	-	[{"date":"2024-09-30","value":"-","profit":true},{"date":"2024-12-31","value":"-","profit":true},{"date":"2025-03-31","value":"-","profit":true},{"date":"2025-06-30","value":"-","profit":true},{"date":"2025-09-30","value":"-","profit":true}]

Income From Continuous Operations	(723.00K)	530.00K	(1.43M)	(324.00K)	(976.00K)	[{"date":"2024-09-30","value":-136.42,"profit":false},{"date":"2024-12-31","value":100,"profit":true},{"date":"2025-03-31","value":-269.62,"profit":false},{"date":"2025-06-30","value":-61.13,"profit":false},{"date":"2025-09-30","value":-184.15,"profit":false}]
Income From Discontinued Operations	-	-	-	-	-	[{"date":"2024-09-30","value":"-","profit":true},{"date":"2024-12-31","value":"-","profit":true},{"date":"2025-03-31","value":"-","profit":true},{"date":"2025-06-30","value":"-","profit":true},{"date":"2025-09-30","value":"-","profit":true}]
Net Income	(723.00K)	530.00K	(1.43M)	(324.00K)	(976.00K)	[{"date":"2024-09-30","value":-136.42,"profit":false},{"date":"2024-12-31","value":100,"profit":true},{"date":"2025-03-31","value":-269.62,"profit":false},{"date":"2025-06-30","value":-61.13,"profit":false},{"date":"2025-09-30","value":-184.15,"profit":false}]

EPS (Diluted)	(0.29)	0.21	(0.56)	(0.11)	(0.30)	[{"date":"2024-09-30","value":-137.46,"profit":false},{"date":"2024-12-31","value":100,"profit":true},{"date":"2025-03-31","value":-268.54,"profit":false},{"date":"2025-06-30","value":-52.83,"profit":false},{"date":"2025-09-30","value":-144.09,"profit":false}]

	Sep '24	Dec '24	Mar '25	Jun '25	Sep '25	TREND
Total Revenue	-	830.93%	(95.51%)	14.81%	840.86%	[{"date":"2024-09-30","value":"-","profit":true},{"date":"2024-12-31","value":98.82,"profit":true},{"date":"2025-03-31","value":-11.36,"profit":false},{"date":"2025-06-30","value":1.76,"profit":true},{"date":"2025-09-30","value":100,"profit":true}]
Cost of Revenue	-	-	-	-	-	[{"date":"2024-09-30","value":"-","profit":true},{"date":"2024-12-31","value":"-","profit":true},{"date":"2025-03-31","value":"-","profit":true},{"date":"2025-06-30","value":"-","profit":true},{"date":"2025-09-30","value":"-","profit":true}]
Gross Profit	-	830.93%	(95.51%)	14.81%	840.86%	[{"date":"2024-09-30","value":"-","profit":true},{"date":"2024-12-31","value":98.82,"profit":true},{"date":"2025-03-31","value":-11.36,"profit":false},{"date":"2025-06-30","value":1.76,"profit":true},{"date":"2025-09-30","value":100,"profit":true}]
Gross Margin	-	-	-	-	-	[{"date":"2024-09-30","value":"-","profit":true},{"date":"2024-12-31","value":"-","profit":true},{"date":"2025-03-31","value":"-","profit":true},{"date":"2025-06-30","value":"-","profit":true},{"date":"2025-09-30","value":"-","profit":true}]

Operating Expenses	-	(1.36%)	17.94%	14.76%	6.57%	[{"date":"2024-09-30","value":"-","profit":true},{"date":"2024-12-31","value":-7.59,"profit":false},{"date":"2025-03-31","value":100,"profit":true},{"date":"2025-06-30","value":82.25,"profit":true},{"date":"2025-09-30","value":36.62,"profit":true}]
Operating Income	-	(144.50%)	(390.24%)	14.76%	(39.83%)	[{"date":"2024-09-30","value":"-","profit":true},{"date":"2024-12-31","value":-979.26,"profit":false},{"date":"2025-03-31","value":-2644.55,"profit":false},{"date":"2025-06-30","value":100,"profit":true},{"date":"2025-09-30","value":-269.93,"profit":false}]
Total Non-Operating Income/Expense	-	(87.47%)	-	2362.50%	(95.65%)	[{"date":"2024-09-30","value":"-","profit":true},{"date":"2024-12-31","value":-3.7,"profit":false},{"date":"2025-03-31","value":"-","profit":true},{"date":"2025-06-30","value":100,"profit":true},{"date":"2025-09-30","value":-4.05,"profit":false}]
Pre-Tax Income	-	(173.31%)	(369.62%)	(77.33%)	201.23%	[{"date":"2024-09-30","value":"-","profit":true},{"date":"2024-12-31","value":-86.12,"profit":false},{"date":"2025-03-31","value":-183.68,"profit":false},{"date":"2025-06-30","value":-38.43,"profit":false},{"date":"2025-09-30","value":100,"profit":true}]
Income Taxes	-	-	-	-	-	[{"date":"2024-09-30","value":"-","profit":true},{"date":"2024-12-31","value":"-","profit":true},{"date":"2025-03-31","value":"-","profit":true},{"date":"2025-06-30","value":"-","profit":true},{"date":"2025-09-30","value":"-","profit":true}]
Income After Taxes	-	-	-	-	-	[{"date":"2024-09-30","value":"-","profit":true},{"date":"2024-12-31","value":"-","profit":true},{"date":"2025-03-31","value":"-","profit":true},{"date":"2025-06-30","value":"-","profit":true},{"date":"2025-09-30","value":"-","profit":true}]

Income From Continuous Operations	-	(173.31%)	(369.62%)	(77.33%)	201.23%	[{"date":"2024-09-30","value":"-","profit":true},{"date":"2024-12-31","value":-86.12,"profit":false},{"date":"2025-03-31","value":-183.68,"profit":false},{"date":"2025-06-30","value":-38.43,"profit":false},{"date":"2025-09-30","value":100,"profit":true}]
Income From Discontinued Operations	-	-	-	-	-	[{"date":"2024-09-30","value":"-","profit":true},{"date":"2024-12-31","value":"-","profit":true},{"date":"2025-03-31","value":"-","profit":true},{"date":"2025-06-30","value":"-","profit":true},{"date":"2025-09-30","value":"-","profit":true}]
Net Income	-	(173.31%)	(369.62%)	(77.33%)	201.23%	[{"date":"2024-09-30","value":"-","profit":true},{"date":"2024-12-31","value":-86.12,"profit":false},{"date":"2025-03-31","value":-183.68,"profit":false},{"date":"2025-06-30","value":-38.43,"profit":false},{"date":"2025-09-30","value":100,"profit":true}]

EPS (Diluted)	-	(172.75%)	(368.54%)	(80.33%)	172.73%	[{"date":"2024-09-30","value":"-","profit":true},{"date":"2024-12-31","value":-100.01,"profit":false},{"date":"2025-03-31","value":-213.37,"profit":false},{"date":"2025-06-30","value":-46.5,"profit":false},{"date":"2025-09-30","value":100,"profit":true}]

	Dec '20	Dec '21	Dec '22	Dec '23	Dec '24	5YR TREND
Total Assets
Current Assets	58.50M	55.46M	14.82M	8.02M	4.22M	[{"date":"2020-12-31","value":100,"profit":true},{"date":"2021-12-31","value":94.8,"profit":true},{"date":"2022-12-31","value":25.33,"profit":true},{"date":"2023-12-31","value":13.72,"profit":true},{"date":"2024-12-31","value":7.22,"profit":true}]
Non-current Assets	56.88M	3.87M	3.26M	5.35M	5.35M	[{"date":"2020-12-31","value":100,"profit":true},{"date":"2021-12-31","value":6.81,"profit":true},{"date":"2022-12-31","value":5.73,"profit":true},{"date":"2023-12-31","value":9.41,"profit":true},{"date":"2024-12-31","value":9.41,"profit":true}]
Total Assets	115.38M	59.33M	18.08M	13.37M	9.57M	[{"date":"2020-12-31","value":100,"profit":true},{"date":"2021-12-31","value":51.42,"profit":true},{"date":"2022-12-31","value":15.67,"profit":true},{"date":"2023-12-31","value":11.59,"profit":true},{"date":"2024-12-31","value":8.3,"profit":true}]

Total Liabilities
Current Liabilities	16.95M	11.09M	7.63M	2.09M	725.00K	[{"date":"2020-12-31","value":100,"profit":true},{"date":"2021-12-31","value":65.39,"profit":true},{"date":"2022-12-31","value":44.99,"profit":true},{"date":"2023-12-31","value":12.31,"profit":true},{"date":"2024-12-31","value":4.28,"profit":true}]
Non-current Liabilities	38.93M	1.83M	2.97M	-	-	[{"date":"2020-12-31","value":100,"profit":true},{"date":"2021-12-31","value":4.7,"profit":true},{"date":"2022-12-31","value":7.63,"profit":true},{"date":"2023-12-31","value":"-","profit":true},{"date":"2024-12-31","value":"-","profit":true}]
Total Liabilities	55.88M	11.09M	7.63M	2.09M	725.00K	[{"date":"2020-12-31","value":100,"profit":true},{"date":"2021-12-31","value":19.84,"profit":true},{"date":"2022-12-31","value":13.65,"profit":true},{"date":"2023-12-31","value":3.73,"profit":true},{"date":"2024-12-31","value":1.3,"profit":true}]

Total Shareholders' equity
Common Stock	-	-	-	-	-	[{"date":"2020-12-31","value":"-","profit":true},{"date":"2021-12-31","value":"-","profit":true},{"date":"2022-12-31","value":"-","profit":true},{"date":"2023-12-31","value":"-","profit":true},{"date":"2024-12-31","value":"-","profit":true}]
Retained Earnings	(163.43M)	(215.08M)	(259.15M)	(264.42M)	(267.49M)	[{"date":"2020-12-31","value":-16342900000,"profit":false},{"date":"2021-12-31","value":-21507600000,"profit":false},{"date":"2022-12-31","value":-25915400000,"profit":false},{"date":"2023-12-31","value":-26441700000,"profit":false},{"date":"2024-12-31","value":-26749200000,"profit":false}]
Other Stockholders' Equity	222.95M	263.35M	269.63M	275.72M	276.34M	[{"date":"2020-12-31","value":80.68,"profit":true},{"date":"2021-12-31","value":95.3,"profit":true},{"date":"2022-12-31","value":97.57,"profit":true},{"date":"2023-12-31","value":99.77,"profit":true},{"date":"2024-12-31","value":100,"profit":true}]
Total Shareholders' equity	59.49M	48.25M	10.45M	11.29M	8.85M	[{"date":"2020-12-31","value":100,"profit":true},{"date":"2021-12-31","value":81.1,"profit":true},{"date":"2022-12-31","value":17.57,"profit":true},{"date":"2023-12-31","value":18.97,"profit":true},{"date":"2024-12-31","value":14.88,"profit":true}]

Total Liabilities & Shareholders Equity	115.38M	59.33M	18.08M	13.37M	9.57M	[{"date":"2020-12-31","value":100,"profit":true},{"date":"2021-12-31","value":51.42,"profit":true},{"date":"2022-12-31","value":15.67,"profit":true},{"date":"2023-12-31","value":11.59,"profit":true},{"date":"2024-12-31","value":8.3,"profit":true}]

	Dec '20	Dec '21	Dec '22	Dec '23	Dec '24	5YR TREND
Total Assets
Current Assets	-	(5.20%)	(73.28%)	(45.86%)	(47.35%)	[{"date":"2020-12-31","value":"-","profit":true},{"date":"2021-12-31","value":null,"profit":false},{"date":"2022-12-31","value":null,"profit":false},{"date":"2023-12-31","value":null,"profit":false},{"date":"2024-12-31","value":null,"profit":false}]
Non-current Assets	-	(93.19%)	(15.88%)	64.16%	-	[{"date":"2020-12-31","value":"-","profit":true},{"date":"2021-12-31","value":-145.24,"profit":false},{"date":"2022-12-31","value":-24.74,"profit":false},{"date":"2023-12-31","value":100,"profit":true},{"date":"2024-12-31","value":"-","profit":true}]
Total Assets	-	(48.58%)	(69.53%)	(26.02%)	(28.41%)	[{"date":"2020-12-31","value":"-","profit":true},{"date":"2021-12-31","value":null,"profit":false},{"date":"2022-12-31","value":null,"profit":false},{"date":"2023-12-31","value":null,"profit":false},{"date":"2024-12-31","value":null,"profit":false}]

Total Liabilities
Current Liabilities	-	(34.61%)	(31.20%)	(72.65%)	(65.24%)	[{"date":"2020-12-31","value":"-","profit":true},{"date":"2021-12-31","value":null,"profit":false},{"date":"2022-12-31","value":null,"profit":false},{"date":"2023-12-31","value":null,"profit":false},{"date":"2024-12-31","value":null,"profit":false}]
Non-current Liabilities	-	(95.30%)	62.47%	-	-	[{"date":"2020-12-31","value":"-","profit":true},{"date":"2021-12-31","value":-152.55,"profit":false},{"date":"2022-12-31","value":100,"profit":true},{"date":"2023-12-31","value":"-","profit":true},{"date":"2024-12-31","value":"-","profit":true}]
Total Liabilities	-	(80.16%)	(31.20%)	(72.65%)	(65.24%)	[{"date":"2020-12-31","value":"-","profit":true},{"date":"2021-12-31","value":null,"profit":false},{"date":"2022-12-31","value":null,"profit":false},{"date":"2023-12-31","value":null,"profit":false},{"date":"2024-12-31","value":null,"profit":false}]

Total Shareholders' equity
Common Stock	-	-	-	-	-	[{"date":"2020-12-31","value":"-","profit":true},{"date":"2021-12-31","value":"-","profit":true},{"date":"2022-12-31","value":"-","profit":true},{"date":"2023-12-31","value":"-","profit":true},{"date":"2024-12-31","value":"-","profit":true}]
Retained Earnings	-	31.60%	20.49%	2.03%	1.16%	[{"date":"2020-12-31","value":"-","profit":true},{"date":"2021-12-31","value":100,"profit":true},{"date":"2022-12-31","value":64.85,"profit":true},{"date":"2023-12-31","value":6.43,"profit":true},{"date":"2024-12-31","value":3.68,"profit":true}]
Other Stockholders' Equity	-	18.12%	2.39%	2.26%	0.23%	[{"date":"2020-12-31","value":"-","profit":true},{"date":"2021-12-31","value":100,"profit":true},{"date":"2022-12-31","value":13.16,"profit":true},{"date":"2023-12-31","value":12.47,"profit":true},{"date":"2024-12-31","value":1.25,"profit":true}]
Total Shareholders' equity	-	(18.90%)	(78.34%)	8.00%	(21.60%)	[{"date":"2020-12-31","value":"-","profit":true},{"date":"2021-12-31","value":-236.35,"profit":false},{"date":"2022-12-31","value":-979.39,"profit":false},{"date":"2023-12-31","value":100,"profit":true},{"date":"2024-12-31","value":-270.03,"profit":false}]

Total Liabilities & Shareholders Equity	-	(48.58%)	(69.53%)	(26.02%)	(28.41%)	[{"date":"2020-12-31","value":"-","profit":true},{"date":"2021-12-31","value":null,"profit":false},{"date":"2022-12-31","value":null,"profit":false},{"date":"2023-12-31","value":null,"profit":false},{"date":"2024-12-31","value":null,"profit":false}]

	Sep '24	Dec '24	Mar '25	Jun '25	Sep '25	TREND
Total Assets
Current Assets	3.55M	4.22M	4.50M	4.02M	5.07M	[{"date":"2024-09-30","value":70.05,"profit":true},{"date":"2024-12-31","value":83.42,"profit":true},{"date":"2025-03-31","value":88.79,"profit":true},{"date":"2025-06-30","value":79.37,"profit":true},{"date":"2025-09-30","value":100,"profit":true}]
Non-current Assets	5.35M	5.35M	5.35M	5.35M	5.35M	[{"date":"2024-09-30","value":100,"profit":true},{"date":"2024-12-31","value":100,"profit":true},{"date":"2025-03-31","value":100,"profit":true},{"date":"2025-06-30","value":100,"profit":true},{"date":"2025-09-30","value":100,"profit":true}]
Total Assets	8.90M	9.57M	9.85M	9.37M	10.41M	[{"date":"2024-09-30","value":85.43,"profit":true},{"date":"2024-12-31","value":91.93,"profit":true},{"date":"2025-03-31","value":94.55,"profit":true},{"date":"2025-06-30","value":89.97,"profit":true},{"date":"2025-09-30","value":100,"profit":true}]

Total Liabilities
Current Liabilities	700.00K	725.00K	1.07M	800.00K	877.00K	[{"date":"2024-09-30","value":65.6,"profit":true},{"date":"2024-12-31","value":67.95,"profit":true},{"date":"2025-03-31","value":100,"profit":true},{"date":"2025-06-30","value":74.98,"profit":true},{"date":"2025-09-30","value":82.19,"profit":true}]
Non-current Liabilities	-	-	-	-	-	[{"date":"2024-09-30","value":"-","profit":true},{"date":"2024-12-31","value":"-","profit":true},{"date":"2025-03-31","value":"-","profit":true},{"date":"2025-06-30","value":"-","profit":true},{"date":"2025-09-30","value":"-","profit":true}]
Total Liabilities	700.00K	725.00K	1.07M	800.00K	877.00K	[{"date":"2024-09-30","value":65.6,"profit":true},{"date":"2024-12-31","value":67.95,"profit":true},{"date":"2025-03-31","value":100,"profit":true},{"date":"2025-06-30","value":74.98,"profit":true},{"date":"2025-09-30","value":82.19,"profit":true}]

Total Shareholders' equity
Common Stock	-	-	-	-	-	[{"date":"2024-09-30","value":"-","profit":true},{"date":"2024-12-31","value":"-","profit":true},{"date":"2025-03-31","value":"-","profit":true},{"date":"2025-06-30","value":"-","profit":true},{"date":"2025-09-30","value":"-","profit":true}]
Retained Earnings	(268.02M)	(267.49M)	(268.92M)	(269.25M)	(270.22M)	[{"date":"2024-09-30","value":-26802200000,"profit":false},{"date":"2024-12-31","value":-26749200000,"profit":false},{"date":"2025-03-31","value":-26892100000,"profit":false},{"date":"2025-06-30","value":-26924500000,"profit":false},{"date":"2025-09-30","value":-27022100000,"profit":false}]
Other Stockholders' Equity	276.22M	276.34M	277.70M	277.81M	279.76M	[{"date":"2024-09-30","value":98.73,"profit":true},{"date":"2024-12-31","value":98.78,"profit":true},{"date":"2025-03-31","value":99.26,"profit":true},{"date":"2025-06-30","value":99.31,"profit":true},{"date":"2025-09-30","value":100,"profit":true}]
Total Shareholders' equity	8.20M	8.85M	8.78M	8.57M	9.54M	[{"date":"2024-09-30","value":85.95,"profit":true},{"date":"2024-12-31","value":92.79,"profit":true},{"date":"2025-03-31","value":92.05,"profit":true},{"date":"2025-06-30","value":89.85,"profit":true},{"date":"2025-09-30","value":100,"profit":true}]

Total Liabilities & Shareholders Equity	8.90M	9.57M	9.85M	9.37M	10.41M	[{"date":"2024-09-30","value":85.43,"profit":true},{"date":"2024-12-31","value":91.93,"profit":true},{"date":"2025-03-31","value":94.55,"profit":true},{"date":"2025-06-30","value":89.97,"profit":true},{"date":"2025-09-30","value":100,"profit":true}]

	Sep '24	Dec '24	Mar '25	Jun '25	Sep '25	TREND
Total Assets
Current Assets	-	19.08%	6.44%	(10.61%)	26.00%	[{"date":"2024-09-30","value":"-","profit":true},{"date":"2024-12-31","value":73.4,"profit":true},{"date":"2025-03-31","value":24.77,"profit":true},{"date":"2025-06-30","value":-40.8,"profit":false},{"date":"2025-09-30","value":100,"profit":true}]
Non-current Assets	-	-	-	-	-	[{"date":"2024-09-30","value":"-","profit":true},{"date":"2024-12-31","value":"-","profit":true},{"date":"2025-03-31","value":"-","profit":true},{"date":"2025-06-30","value":"-","profit":true},{"date":"2025-09-30","value":"-","profit":true}]
Total Assets	-	7.61%	2.84%	(4.84%)	11.15%	[{"date":"2024-09-30","value":"-","profit":true},{"date":"2024-12-31","value":68.22,"profit":true},{"date":"2025-03-31","value":25.47,"profit":true},{"date":"2025-06-30","value":-43.43,"profit":false},{"date":"2025-09-30","value":100,"profit":true}]

Total Liabilities
Current Liabilities	-	3.57%	47.17%	(25.02%)	9.63%	[{"date":"2024-09-30","value":"-","profit":true},{"date":"2024-12-31","value":7.57,"profit":true},{"date":"2025-03-31","value":100,"profit":true},{"date":"2025-06-30","value":-53.05,"profit":false},{"date":"2025-09-30","value":20.4,"profit":true}]
Non-current Liabilities	-	-	-	-	-	[{"date":"2024-09-30","value":"-","profit":true},{"date":"2024-12-31","value":"-","profit":true},{"date":"2025-03-31","value":"-","profit":true},{"date":"2025-06-30","value":"-","profit":true},{"date":"2025-09-30","value":"-","profit":true}]
Total Liabilities	-	3.57%	47.17%	(25.02%)	9.63%	[{"date":"2024-09-30","value":"-","profit":true},{"date":"2024-12-31","value":7.57,"profit":true},{"date":"2025-03-31","value":100,"profit":true},{"date":"2025-06-30","value":-53.05,"profit":false},{"date":"2025-09-30","value":20.4,"profit":true}]

Total Shareholders' equity
Common Stock	-	-	-	-	-	[{"date":"2024-09-30","value":"-","profit":true},{"date":"2024-12-31","value":"-","profit":true},{"date":"2025-03-31","value":"-","profit":true},{"date":"2025-06-30","value":"-","profit":true},{"date":"2025-09-30","value":"-","profit":true}]
Retained Earnings	-	(0.20%)	0.53%	0.12%	0.36%	[{"date":"2024-09-30","value":"-","profit":true},{"date":"2024-12-31","value":-37.02,"profit":false},{"date":"2025-03-31","value":100,"profit":true},{"date":"2025-06-30","value":22.55,"profit":true},{"date":"2025-09-30","value":67.85,"profit":true}]
Other Stockholders' Equity	-	0.04%	0.49%	0.04%	0.70%	[{"date":"2024-09-30","value":"-","profit":true},{"date":"2024-12-31","value":6.31,"profit":true},{"date":"2025-03-31","value":70.28,"profit":true},{"date":"2025-06-30","value":5.87,"profit":true},{"date":"2025-09-30","value":100,"profit":true}]
Total Shareholders' equity	-	7.95%	(0.79%)	(2.39%)	11.30%	[{"date":"2024-09-30","value":"-","profit":true},{"date":"2024-12-31","value":70.41,"profit":true},{"date":"2025-03-31","value":-7,"profit":false},{"date":"2025-06-30","value":-21.18,"profit":false},{"date":"2025-09-30","value":100,"profit":true}]

Total Liabilities & Shareholders Equity	-	7.61%	2.84%	(4.84%)	11.15%	[{"date":"2024-09-30","value":"-","profit":true},{"date":"2024-12-31","value":68.22,"profit":true},{"date":"2025-03-31","value":25.47,"profit":true},{"date":"2025-06-30","value":-43.43,"profit":false},{"date":"2025-09-30","value":100,"profit":true}]

	Dec '20	Dec '21	Dec '22	Dec '23	Dec '24	5YR TREND
Operating Activities
Net Operating Cash Flow	(72.49M)	(36.52M)	(40.61M)	(21.25M)	(4.33M)	[{"date":"2020-12-31","value":-7249000000,"profit":false},{"date":"2021-12-31","value":-3651700000,"profit":false},{"date":"2022-12-31","value":-4061100000,"profit":false},{"date":"2023-12-31","value":-2124500000,"profit":false},{"date":"2024-12-31","value":-433300000,"profit":false}]

Investing Activities
Net Investing Cash Flow	18.00K	1.46M	-	10.40M	-	[{"date":"2020-12-31","value":0.17,"profit":true},{"date":"2021-12-31","value":14.01,"profit":true},{"date":"2022-12-31","value":"-","profit":true},{"date":"2023-12-31","value":100,"profit":true},{"date":"2024-12-31","value":"-","profit":true}]

Financing Activities
Net Financing Cash Flow	28.09M	30.79M	29.00K	5.02M	-	[{"date":"2020-12-31","value":91.25,"profit":true},{"date":"2021-12-31","value":100,"profit":true},{"date":"2022-12-31","value":0.09,"profit":true},{"date":"2023-12-31","value":16.32,"profit":true},{"date":"2024-12-31","value":"-","profit":true}]

Net Change in Cash	(44.39M)	(4.27M)	(40.58M)	(5.81M)	(4.34M)	[{"date":"2020-12-31","value":-4438900000,"profit":false},{"date":"2021-12-31","value":-427100000,"profit":false},{"date":"2022-12-31","value":-4057900000,"profit":false},{"date":"2023-12-31","value":-581100000,"profit":false},{"date":"2024-12-31","value":-433900000,"profit":false}]

Free Cash Flow
Free Cash Flow	(74.01M)	(36.52M)	(40.61M)	(21.25M)	(4.33M)	[{"date":"2020-12-31","value":-7401400000,"profit":false},{"date":"2021-12-31","value":-3652400000,"profit":false},{"date":"2022-12-31","value":-4061100000,"profit":false},{"date":"2023-12-31","value":-2124500000,"profit":false},{"date":"2024-12-31","value":-433300000,"profit":false}]

	Dec '20	Dec '21	Dec '22	Dec '23	Dec '24	5YR TREND
Operating Activities
Net Operating Cash Flow	-	(49.62%)	11.21%	(47.69%)	(79.60%)	[{"date":"2020-12-31","value":"-","profit":true},{"date":"2021-12-31","value":-442.64,"profit":false},{"date":"2022-12-31","value":100,"profit":true},{"date":"2023-12-31","value":-425.35,"profit":false},{"date":"2024-12-31","value":-710.04,"profit":false}]

Investing Activities
Net Investing Cash Flow	-	7994.44%	-	-	-	[{"date":"2020-12-31","value":"-","profit":true},{"date":"2021-12-31","value":100,"profit":true},{"date":"2022-12-31","value":"-","profit":true},{"date":"2023-12-31","value":"-","profit":true},{"date":"2024-12-31","value":"-","profit":true}]

Financing Activities
Net Financing Cash Flow	-	9.59%	(99.91%)	17224.14%	-	[{"date":"2020-12-31","value":"-","profit":true},{"date":"2021-12-31","value":0.06,"profit":true},{"date":"2022-12-31","value":-0.58,"profit":false},{"date":"2023-12-31","value":100,"profit":true},{"date":"2024-12-31","value":"-","profit":true}]

Net Change in Cash	-	(90.38%)	850.11%	(85.68%)	(25.33%)	[{"date":"2020-12-31","value":"-","profit":true},{"date":"2021-12-31","value":-10.63,"profit":false},{"date":"2022-12-31","value":100,"profit":true},{"date":"2023-12-31","value":-10.08,"profit":false},{"date":"2024-12-31","value":-2.98,"profit":false}]

Free Cash Flow
Free Cash Flow	-	(50.65%)	11.19%	(47.69%)	(79.60%)	[{"date":"2020-12-31","value":"-","profit":true},{"date":"2021-12-31","value":-452.66,"profit":false},{"date":"2022-12-31","value":100,"profit":true},{"date":"2023-12-31","value":-426.16,"profit":false},{"date":"2024-12-31","value":-711.4,"profit":false}]

	Sep '24	Dec '24	Mar '25	Jun '25	Sep '25	TREND
Operating Activities
Net Operating Cash Flow	(1.72M)	360.00K	(968.00K)	(503.00K)	(264.00K)	[{"date":"2024-09-30","value":-476.67,"profit":false},{"date":"2024-12-31","value":100,"profit":true},{"date":"2025-03-31","value":-268.89,"profit":false},{"date":"2025-06-30","value":-139.72,"profit":false},{"date":"2025-09-30","value":-73.33,"profit":false}]

Investing Activities
Net Investing Cash Flow	-	-	-	-	-	[{"date":"2024-09-30","value":"-","profit":true},{"date":"2024-12-31","value":"-","profit":true},{"date":"2025-03-31","value":"-","profit":true},{"date":"2025-06-30","value":"-","profit":true},{"date":"2025-09-30","value":"-","profit":true}]

Financing Activities
Net Financing Cash Flow	-	-	1.38M	(130.00K)	1.83M	[{"date":"2024-09-30","value":"-","profit":true},{"date":"2024-12-31","value":"-","profit":true},{"date":"2025-03-31","value":75.3,"profit":true},{"date":"2025-06-30","value":-7.12,"profit":false},{"date":"2025-09-30","value":100,"profit":true}]

Net Change in Cash	(1.72M)	360.00K	407.00K	(633.00K)	1.56M	[{"date":"2024-09-30","value":-109.86,"profit":false},{"date":"2024-12-31","value":23.05,"profit":true},{"date":"2025-03-31","value":26.06,"profit":true},{"date":"2025-06-30","value":-40.52,"profit":false},{"date":"2025-09-30","value":100,"profit":true}]

Free Cash Flow
Free Cash Flow	(1.72M)	360.00K	(968.00K)	(503.00K)	(264.00K)	[{"date":"2024-09-30","value":-476.67,"profit":false},{"date":"2024-12-31","value":100,"profit":true},{"date":"2025-03-31","value":-268.89,"profit":false},{"date":"2025-06-30","value":-139.72,"profit":false},{"date":"2025-09-30","value":-73.33,"profit":false}]

	Sep '24	Dec '24	Mar '25	Jun '25	Sep '25	TREND
Operating Activities
Net Operating Cash Flow	-	(120.98%)	(368.89%)	(48.04%)	(47.51%)	[{"date":"2024-09-30","value":"-","profit":true},{"date":"2024-12-31","value":null,"profit":false},{"date":"2025-03-31","value":null,"profit":false},{"date":"2025-06-30","value":null,"profit":false},{"date":"2025-09-30","value":null,"profit":false}]

Investing Activities
Net Investing Cash Flow	-	-	-	-	-	[{"date":"2024-09-30","value":"-","profit":true},{"date":"2024-12-31","value":"-","profit":true},{"date":"2025-03-31","value":"-","profit":true},{"date":"2025-06-30","value":"-","profit":true},{"date":"2025-09-30","value":"-","profit":true}]

Financing Activities
Net Financing Cash Flow	-	-	-	(109.45%)	(1504.62%)	[{"date":"2024-09-30","value":"-","profit":true},{"date":"2024-12-31","value":"-","profit":true},{"date":"2025-03-31","value":"-","profit":true},{"date":"2025-06-30","value":null,"profit":false},{"date":"2025-09-30","value":null,"profit":false}]

Net Change in Cash	-	(120.98%)	13.06%	(255.53%)	(346.76%)	[{"date":"2024-09-30","value":"-","profit":true},{"date":"2024-12-31","value":-926.65,"profit":false},{"date":"2025-03-31","value":100,"profit":true},{"date":"2025-06-30","value":-1957.24,"profit":false},{"date":"2025-09-30","value":-2656.05,"profit":false}]

Free Cash Flow
Free Cash Flow	-	(120.98%)	(368.89%)	(48.04%)	(47.51%)	[{"date":"2024-09-30","value":"-","profit":true},{"date":"2024-12-31","value":null,"profit":false},{"date":"2025-03-31","value":null,"profit":false},{"date":"2025-06-30","value":null,"profit":false},{"date":"2025-09-30","value":null,"profit":false}]

Cyclerion Therapeutics Inc Ratios

Cyclerion Therapeutics Inc Liquidity Ratios

These ratios help you determine the liquidity of the company. Higher is better.

	CYCN
Cash Ratio	5.21
Current Ratio	5.78

Cyclerion Therapeutics Inc Asset Efficiency Ratios

These ratios help you understand the company's efficiency in using its assets to generate returns. Higher is better. For ROE, average long term is around 14%, less than 10% is poor.

	CYCN
ROA (LTM)	-23.51%
ROE (LTM)	-24.80%

Cyclerion Therapeutics Inc Liability Ratios

These ratios help you understand the company's liabilities, gauging the riskiness of the investment.

	CYCN
Debt Ratio Lower is generally better. Negative is bad.	0.08
Common Equity/Total Assets Higher is better. Lower can suggest investment is riskier.	0.92

Cyclerion Therapeutics Inc Valuation Ratios

These ratios help you understand the company's valuation. Lower may indicate cheaper stocks.

	CYCN
Trailing PE	NM
Forward PE	NM
P/S (TTM)	1.67
P/B	0.50
Price/FCF	NM
EV/R	0.08
EV/Ebitda	0.56

Discover more

Tesla, Inc.

Apple, Inc.

Alphabet Inc. - Class A Shares

Meta Platforms Inc

Amazon.com Inc.

Microsoft Corporation

NVIDIA Corporation

Berkshire Hathaway Inc. Hld B

Eli Lilly and Company

FAQs

What is Cyclerion Therapeutics Inc share price today?

Cyclerion Therapeutics Inc (CYCN) share price today is $1.25

Can Indians buy Cyclerion Therapeutics Inc shares?

Yes, Indians can buy shares of Cyclerion Therapeutics Inc (CYCN) on Vested. To buy

from India, you can open a US Brokerage account on Vested today by clicking on Sign Up or Invest in CYCN stock at the top of this page. The account opening process is completely digital and secure, and takes a few minutes to complete.

Can Fractional shares of Cyclerion Therapeutics Inc be purchased?

Yes, you can purchase fractional shares of Cyclerion Therapeutics Inc (CYCN) via the Vested app. You can start investing in Cyclerion Therapeutics Inc (CYCN) with a minimum investment of $1.

How to invest in Cyclerion Therapeutics Inc shares from India?

You can invest in shares of Cyclerion Therapeutics Inc (CYCN) via Vested in three simple steps:

Click on Sign Up or Invest in CYCN stock at the top of this page
Breeze through our fully digital and secure KYC process and open your US Brokerage account in a few minutes
Transfer USD funds to your US Brokerage account and start investing in Cyclerion Therapeutics Inc shares

What is Cyclerion Therapeutics Inc 52-week high and low stock price?

The 52-week high price of Cyclerion Therapeutics Inc (CYCN) is $3.79. The 52-week low price of Cyclerion Therapeutics Inc (CYCN) is $1.03.

What is Cyclerion Therapeutics Inc price-to-earnings (P/E) ratio?

The price-to-earnings (P/E) ratio of Cyclerion Therapeutics Inc (CYCN) is

What is Cyclerion Therapeutics Inc price-to-book (P/B) ratio?

The price-to-book (P/B) ratio of Cyclerion Therapeutics Inc (CYCN) is 0.50

What is Cyclerion Therapeutics Inc dividend yield?

The dividend yield of Cyclerion Therapeutics Inc (CYCN) is 0.00%

What is the Market Cap of Cyclerion Therapeutics Inc?

The market capitalization of Cyclerion Therapeutics Inc (CYCN) is $4.76M

What is Cyclerion Therapeutics Inc's stock symbol?

The stock symbol (or ticker) of Cyclerion Therapeutics Inc is CYCN

How Can Investors Use Cyclerion Therapeutics Inc Share Price Data for Long-Term Investment Decisions?

Consider the share price of Cyclerion Therapeutics Inc as a long-term story and not a daily point list. The price represents a movement of the stock in both good and bad times when looked at over many years. This assists the investors to know whether Cyclerion Therapeutics Inc has succeeded to expand steadily and overcome market declines. With this price movement observed and the way the business is progressing, it is easier to make a decision whether the stock is worth having in the long term or not.

How does USD - INR currency movement impact returns from Cyclerion Therapeutics Inc shares for Indian investors?

When investing in Cyclerion Therapeutics Inc shares, you are not based in India then your investment is not just based on the stock price. It is also determined by the currency movement of the dollar in relation to the rupee. When you have an appreciation of the Cyclerion Therapeutics Inc stock and the dollar appreciation is also the same, you gain more in terms of rupees. When the rupee appreciated, it will lower your profits. This currency flow is a silent cause of great contribution to your ultimate returns over many years.

How should investors compare Cyclerion Therapeutics Inc share price with other stocks in the same sector?

Rather than merely checking the share price of Cyclerion Therapeutics Inc and comparing it with that of other stocks in the same sector, one can check how robust the business is. Investors tend to compare such aspects as profits, cash generation, and the stability of the revenues of the company. This means that Cyclerion Therapeutics Inc stock in most cases does not react in the same manner as other companies in the sector due to its brand and services revenue.

Feedback

Request to add more info/data

Inform about wrong info/data

Link copied

Signup to access all features and start your US investing journey!

Open your account in minutes
Take your portfolio global, starting at just $1

Get started

Add ticker to compare

Apple, Inc AAPL
Alphabet Inc. - Class A Shares GOOGL
Microsoft Corporation MSFT
Meta Platforms Inc META
Netflix, Inc. NFLX
Amazon.com Inc. AMZN
Spotify Technology SA SPOT

US Stocks & ETFs

Private Markets

Managed Portfolios (Previously Vests)

Global Funds

Global

Explore our India Diversification

INR Bonds

Alt FDs

Cyclerion Therapeutics Inc Share Price

Cyclerion Therapeutics Inc Analyst Forecast

Cyclerion Therapeutics Inc Share Price Chart

Cyclerion Therapeutics Inc Key Stock Metrics

About Cyclerion Therapeutics Inc, Common Stock

Cyclerion Therapeutics Inc Stock Returns

Cyclerion Therapeutics Inc Financials

Cyclerion Therapeutics Inc Ratios

Cyclerion Therapeutics Inc Liquidity Ratios

Cyclerion Therapeutics Inc Asset Efficiency Ratios

Cyclerion Therapeutics Inc Liability Ratios

Cyclerion Therapeutics Inc Valuation Ratios

Discover more

FAQs

Feedback

Signup to access all features and start your US investing journey!

Add ticker to compare

Company

Explore Products

Popular US Stocks ¹

Popular US ETFs ²

Curated Portfolios (Vests)

Risk Disclosure - US Markets

US Stocks & ETFs

Private Markets

Managed Portfolios (Previously Vests)

Global Funds

Global

Explore our India Diversification

INR Bonds

Alt FDs

Cyclerion Therapeutics Inc Share Price

Cyclerion Therapeutics Inc Analyst Forecast

Cyclerion Therapeutics Inc Share Price Chart

Cyclerion Therapeutics Inc Key Stock Metrics

About Cyclerion Therapeutics Inc, Common Stock

Cyclerion Therapeutics Inc Stock Returns

Cyclerion Therapeutics Inc Financials

Cyclerion Therapeutics Inc Ratios

Cyclerion Therapeutics Inc Liquidity Ratios

Cyclerion Therapeutics Inc Asset Efficiency Ratios

Cyclerion Therapeutics Inc Liability Ratios

Cyclerion Therapeutics Inc Valuation Ratios

Discover more

FAQs

Feedback

Signup to access all features and start your US investing journey!

Add ticker to compare

Popular US Stocks 1

Popular US ETFs 2

Curated Portfolios (Vests)

Popular US Stocks ¹

Popular US ETFs ²